ImageneBio (IMA) Stock Chart & Stock Price History $14.67 -0.03 (-0.20%) As of 08/8/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ImageneBio Stock Price Performance The ImageneBio (IMA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 24.77%, with a year-to-date return of -25.46%. In the past month, the stock has decreased 12.05%, reflecting recent market activity. As of the latest close, ImageneBio traded at $14.67 with a market cap of $58.97 million and volume of 5,894 shares. Receive IMA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ImageneBio and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-11.04%1 Month Performance-12.05%3 Month Performance+7.71%Year-To-Date Performance-25.46%1 Year Performance-24.77% IMA Stock Chart for Sunday, August, 10, 2025 IMA Chart by TradingView ImageneBio Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$14.70$14.67-0.20%$15.79$14.055,894 shs$58.97 million08/07/2025$15.75$14.70-6.67%$15.75$14.7010,170 shs$59.09 million08/06/2025$16.49$15.75-4.49%$16.47$15.752,759 shs$63.32 million08/05/2025$16.60$16.49-0.66%$16.50$15.6018,402 shs$66.29 million08/04/2025$17.28$16.60-3.94%$17.50$16.4253,611 shs$66.73 million08/01/2025$17.90$17.28-3.46%$17.90$17.1011,207 shs$69.47 million07/31/2025$15.29$17.90+17.07%$17.96$15.03122,160 shs$71.96 million07/30/2025$15.20$15.29+0.59%$15.81$15.1421,220 shs$61.47 million07/29/2025N/A$15.20$16.00$15.2025,455 shs$733.55 million07/25/2025$16.44$17.16+4.38%$17.76$16.3237,095 shs$69.01 million Get the Latest News and Ratings for IMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ImageneBio and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025$16.56$16.44-0.72%$16.68$15.6032,770 shs$66.12 million07/23/2025$14.88$16.56+11.29%$17.04$15.3653,048 shs$66.60 million07/22/2025$15.24$14.88-2.36%$15.36$14.40106,735 shs$59.84 million07/21/2025$15.24$15.24$15.48$15.0052,409 shs$61.29 million07/18/2025$15.12$15.24+0.79%$15.47$14.8821,637 shs$61.29 million07/17/2025$15.48$15.12-2.33%$15.54$15.1242,912 shs$60.81 million07/16/2025$17.04$15.48-9.15%$16.56$15.1294,831 shs$62.26 million07/15/2025$16.44$17.04+3.65%$17.64$16.08153,337 shs$68.53 million07/14/2025$16.56$16.44-0.72%$17.13$15.9674,201 shs$66.11 million07/11/2025$16.68$16.56-0.72%$16.82$16.203,356 shs$66.60 million07/10/2025$16.08$16.68+3.73%$16.80$15.841,432 shs$67.08 million07/09/2025$16.44$16.08-2.19%$16.54$15.7217,079 shs$64.67 million Related Companies DRUG Stock Chart CLDI Stock Chart MNPR Stock Chart ALLO Stock Chart TVRD Stock Chart DSGN Stock Chart GALT Stock Chart ALMS Stock Chart TKNO Stock Chart ACIU Stock Chart Receive IMA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ImageneBio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IMA) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImageneBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImageneBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
